Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children

Parasites and Vectors

Volumn 5, Issue 1, 2012, Pages

  Stete, Katarina ^a,b,c,d   Krauth, Stefanie J ^a,c,d   Coulibaly, Jean T ^a,c,d,e   Knopp, Stefanie ^a,d   Hattendorf, Jan ^a,d   Müller, Ivan ^a,c,d   Lohourignon, Laurent K ^e   Kern, Winfried V ^b   N'Goran, Eliézer K ^c,e   Utzinger, Jürg ^a,d  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF FREIBURG   (Germany)

^c CENTRE SUISSE DE RECHERCHES SCIENTIFIQUES EN CÔTE D'IVOIRE   (Côte d’Ivoire)

^d UNIVERSITY OF BASEL   (Switzerland)

^e UNIVERSITÉ FÉLIX HOUPHOUËT BOIGNY   (Côte d’Ivoire)

Author keywords

C te d'Ivoire; Drug efficacy; Leukocyturia; Macrohaematuria; Microhaematuria; Praziquantel; Proteinuria; Schistosoma haematobium; Schistosomiasis; School aged children

Indexed keywords

PRAZIQUANTEL; ANTHELMINTIC AGENT;

ARTICLE; CHILD; CONTROLLED STUDY; DRUG EFFICACY; DRUG MONITORING; EGG PARASITOID; ENDEMIC DISEASE; FEMALE; HEMATURIA; HUMAN; LEUKOCYTURIA; MACROHEMATURIA; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; OUTCOME ASSESSMENT; PREVALENCE; PROTEINURIA; SCHISTOSOMIASIS HAEMATOBIA; SINGLE DRUG DOSE; URINALYSIS; ADOLESCENT; ANIMAL; CLINICAL TRIAL; COTE D'IVOIRE; DRUG EFFECT; ORAL DRUG ADMINISTRATION; PARASITE IDENTIFICATION; PARASITOLOGY; PHYSIOLOGY; SCHISTOSOMA HEMATOBIUM; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADOLESCENT; ANIMALS; ANTHELMINTICS; CHILD; COTE D'IVOIRE; DRUG MONITORING; FEMALE; HUMANS; MALE; PARASITE EGG COUNT; PRAZIQUANTEL; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84871396157     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-5-298     Document Type: Article

References (54)

1. Gryseels B: Schistosomiasis. Infect Dis Clin North Am 2012, 26:383-397.
2. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J: Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 2006, 6:411-425.
3. Hotez PJ, Kamath A: Neglected tropical diseases in sub-Saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis 2009, 3:e412.
4. King CH: Parasites and poverty: the case of schistosomiasis. Acta Trop 2010, 113:95-104.
5. Hotez PJ, Molyneux DH, Fenwick A, Ottesen E, Ehrlich Sachs S, Sachs JD: Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med 2006, 3:e102.
6. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Ehrlich Sachs S, Sachs JD, Savioli L: Control of neglected tropical diseases. N Engl J Med 2007, 357:1018-1027.
7. Utzinger J, Raso G, Brooker S, de Savigny D, Tanner M, Ørnbjerg N, Singer BH, N'Goran EK: Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution. Parasitology 2009, 136:1859-1874.
8. Utzinger J, Becker SL, Knopp S, Blum J, Neumayr AL, Keiser J, Hatz CF: Neglected tropical diseases: diagnosis, clinical management, treatment and control. Swiss Med Wkly 2012, 142:w13727.
9. Gryseels B, Polman K, Clerinx J, Kestens L: Human schistosomiasis. Lancet 2006, 368:1106-1118.
10. Gray DJ, Ross AG, Li YS, McManus DP: Diagnosis and management of schistosomiasis. BMJ 2011, 342:d2651-d2651.
11. Woolhouse MEJ: Patterns in parasite epidemiology: the peak shift. Parasitol Today 1998, 14:428-434.
12. King CH, Dickman K, Tisch DJ: Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 2005, 365:1561-1569.
13. King CH, Dangerfield-Cha M: The unacknowledged impact of chronic schistosomiasis. Chronic Illn 2008, 4:65-79.
14. Peters PA, Mahmoud AA, Warren KS, Ouma JH, Siongok TK: Field studies of a rapid, accurate means of quantifying Schistosoma haematobium eggs in urine samples. Bull World Health Organ 1976, 54:159-162.
15. Utzinger J, N'Goran EK, Caffrey CR, Keiser J: From innovation to application: social-ecological context, diagnostics, drugs and integrated control of schistosomiasis. Acta Trop 2011, 120(Suppl 1):S121-S137.
16. Mott KE, Dixon H, Osei-Tutu E, England EC, Davis A: Effect of praziquantel on hematuria and proteinuria in urinary schistosomiasis. Am J Trop Med Hyg 1985, 34:1119-1126.
17. Rollinson D, Klinger EV, Mgeni AF, Khamis IS, Stothard JR: Urinary schistosomiasis on Zanzibar: application of two novel assays for the detection of excreted albumin and haemoglobin in urine. J Helminthol 2005, 79:199-206.
18. French MD, Rollinson D, Basáñez M-G, Mgeni AF, Khamis IS, Stothard JR: School-based control of urinary schistosomiasis on Zanzibar, Tanzania: monitoring micro-haematuria with reagent strips as a rapid urological assessment. J Pediatr Urol 2007, 3:364-368.
19. Fenwick A, Savioli L, Engels D, Bergquist NR, Todd MH: Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol 2003, 19:509-515.
20. Utzinger J, Keiser J: Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control. Expert Opin Pharmacother 2004, 5:263-285.
21. Doenhoff MJ, Cioli D, Utzinger J: Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 2008, 21:659-667.
22. Sabah AA, Fletcher C, Webbe G, Doenhoff MJ: Schistosoma mansoni: chemotherapy of infections of different ages. Exp Parasitol 1986, 61:294-303.
23. Botros S, Pica-Mattoccia L, William S, El-Lakkani N, Cioli D: Effect of praziquantel on the immature stages of Schistosoma haematobium. Int J Parasitol 2005, 35:1453-1457.
24. Doenhoff MJ, Hagan P, Cioli D, Southgate V, Pica-Mattoccia L, Botros S, Coles GC, Tchuem Tchuenté L-A, Mbaye A, Engels D: Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs. Parasitology 2009, 136:1825-1835.
25. Keiser J, N'Guessan NA, Adoubryn KD, Silué KD, Vounatsou P, Hatz C, Utzinger J, N'Goran EK: Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial. Clin Infect Dis 2010, 50:1205-1213.
26. World Health Organization: Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee. WHO Tech Rep Ser 2002, 912:1-57.
27. World Health Organization: Preventive chemotherapy in human helminthiasis: coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. Geneva: World Health Organization; 2006:1-62.
28. World Health Organization: Schistosomiasis: population requiring preventive chemotherapy and number of people treated in 2010. Wkly Epidemiol Rec 2012, 87:37-44.
29. Danso-Appiah A, Garner P, Olliaro PL, Utzinger J: Treatment of urinary schistosomiasis: methodological issues and research needs identified through a Cochrane systematic review. Parasitology 2009, 136:1837-1849.
30. Müller I, Coulibaly JT, Fürst T, Knopp S, Hattendorf J, Krauth SJ, Stete K, Righetti AA, Glinz D, Yao AK, Pühse U, N'Goran EK, Utzinger J: Effect of schistosomiasis and soil-transmitted helminth infections on physical fitness of school children in Côte d'Ivoire. PLoS Negl Trop Dis 2011, 5:e1239.
31. Fürst T, Müller I, Coulibaly JT, Yao AK, Utzinger J, N'Goran EK: Questionnaire-based approach to assess schoolchildren's physical fitness and its potential role in exploring the putative impact of helminth and Plasmodium spp. infections in Côte d'Ivoire. Parasit Vectors 2011, 4:116.
32. Savioli L, Gabrielli AF, Montresor A, Chitsulo L, Engels D: Schistosomiasis control in Africa: 8 years after World Health Assembly Resolution 54.19. Parasitology 2009, 136:1677-1681.
33. Van Etten L, Kremsner PG, Krijger FW, Deelder AM: Day-to-day variation of egg output and schistosome circulating antigens in urine of Schistosoma haematobium-infected school children from Gabon and follow-up after chemotherapy. Am J Trop Med Hyg 1997, 57:337-341.
34. Saathoff E, Olsen A, Magnussen P, Kvalsvig JD, Becker W, Appleton CC: Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa. BMC Infect Dis 2004, 4:40.
35. Tchuem Tchuenté L-A, Shaw DJ, Polla L, Cioli D, Vercruysse J: Efficacy of praziquantel against Schistosoma haematobium infection in children. Am J Trop Med Hyg 2004, 71:778-782.
36. Ghandour AM: The development of Schistosoma haematobium in the hamster. Ann Trop Med Parasitol 1978, 72:219-225.
37. Augusto G, Magnussen P, Kristensen TK, Appleton CC, Vennervald BJ: The influence of transmission season on parasitological cure rates and intensity of infection after praziquantel treatment of Schistosoma haematobium-infected schoolchildren in Mozambique. Parasitology 2009, 136:1771-1779.
38. Scherrer AU, Sjöberg MK, Allangba A, Traoré M, Lohourignon LK, Tschannen AB, N'Goran EK, Utzinger J: Sequential analysis of helminth egg output in human stool samples following albendazole and praziquantel administration. Acta Trop 2009, 109:226-231.
39. Smith M, Clegg JA, Webbe G: Culture of Schistosoma haematobium in vivo and in vitro. Ann Trop Med Parasitol 1976, 70:101-107.
40. Utzinger J, N'Goran EK, N'Dri A, Lengeler C, Xiao SH, Tanner M: Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial. Lancet 2000, 355:1320-1325.
41. N'Goran EK, Gnaka HN, Tanner M, Utzinger J: Efficacy and side-effects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from Côte d'Ivoire. Ann Trop Med Parasitol 2003, 97:37-51.
42. Midzi N, Sangweme D, Zinyowera S, Mapingure MP, Brouwer KC, Kumar N, Mutapi F, Woelk G, Mduluza T: Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe. Trans R Soc Trop Med Hyg 2008, 102:759-766.
43. Garba A, Barkiré N, Djibo A, Lamine MS, Sofo B, Gouvras AN, Bosqué-Oliva E, Webster JP, Stothard JR, Utzinger J, Fenwick A: Schistosomiasis in infants and preschool-aged children: infection in a single Schistosoma haematobium and a mixed S. haematobium-S. mansoni foci of Niger. Acta Trop 2010, 115:212-219.
44. Coulibaly JT, Fürst T, Silué KD, Knopp S, Hauri D, Ouattara M, Utzinger J, N'Goran EK: Intestinal parasitic infections in schoolchildren in different settings of Côte d'Ivoire: effect of diagnostic approach and implications for control. Parasit Vectors 2012, 5:135.
45. Meurs L, Mbow M, Vereecken K, Menten J, Mboup S, Polman K: Epidemiology of mixed Schistosoma mansoni and Schistosoma haematobium infections in northern Senegal. Int J Parasitol 2012, 42:305-311.
46. Wu W, Wang W, Huang Y-X: New insight into praziquantel against various developmental stages of schistosomes. Parasitol Res 2011, 109:1501-1507.
47. Doehring E, Ehrich JH, Vester U, Feldmeier H, Poggensee U, Brodehl J: Proteinuria, hematuria, and leukocyturia in children with mixed urinary and intestinal schistosomiasis. Kidney Int 1985, 28:520-525.
48. Doehring E, Reider F, Schmidt-Ehry G, Ehrich JH: Reduction of pathological findings in urine and bladder lesions in infection with Schistosoma haematobium after treatment with praziquantel. J Infect Dis 1985, 152:807-810.
49. Sarda RK, Kihamia CM, Minjas JN, Mahikwano LF: Haematuria and proteinuria in urinary schistosomiasis: response to therapy with praziquantel in Tanzanian children. Trop Med Parasitol 1987, 38:31-33.
50. Inyang-Etoh PC, Ejezie GC, Useh MF, Inyang-Etoh EC: Efficacy of a combination of praziquantel and artesunate in the treatment of urinary schistosomiasis in Nigeria. Trans R Soc Trop Med Hyg 2009, 103:38-44.
51. Kahama AI, Vennervald BJ, Kombe Y, Kihara RW, Ndzovu M, Mungai P, Ouma JH: Parameters associated with Schistosoma haematobium infection before and after chemotherapy in school children from two villages in the Coast province of Kenya. Trop Med Int Health 1999, 4:335-340.
52. Kahama AI, Odek AE, Kihara RW, Vennervald BJ, Kombe Y, Nkulila T, Hatz C, Ouma JH, Deelder AM: Urine circulating soluble egg antigen in relation to egg counts, hematuria, and urinary tract pathology before and after treatment in children infected with Schistosoma haematobium in Kenya. Am J Trop Med Hyg 1999, 61:215-219.
53. Hatz C, Vennervald BJ, Nkulila T, Vounatsou P, Kombe Y, Mayombana C, Mshinda H, Tanner M: Evolution of Schistosoma haematobium-related pathology over 24 months after treatment with praziquantel among school children in southeastern Tanzania. Am J Trop Med Hyg 1998, 59:775-781.
54. Bogoch II, Andrews JR, Dadzie Ephraim RK, Utzinger J: Simple questionnaire and urine reagent strips compared to microscopy for the diagnosis of Schistosoma haematobium in a community in northern Ghana. Trop Med Int Health 2012, 17:1217-1221.